Literature DB >> 20495811

Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.

Matthias Thielmann1, Eva Kottenberg, Kerstin Boengler, Christoph Raffelsieper, Markus Neuhaeuser, Jürgen Peters, Heinz Jakob, Gerd Heusch.   

Abstract

Remote ischemic preconditioning (RIPC) with transient upper limb ischemia reduces myocardial injury in patients undergoing on-pump coronary artery bypass grafting (CABG) with cross-clamp fibrillation or blood cardioplegia for myocardial protection. Whether or not such protection is still operative when standard crystalloid cardioplegic arrest is used is uncertain. Fifty-three consecutive, non-diabetic patients with triple-vessel disease and 64 +/- 12 years of age (mean +/- SD), who underwent elective CABG surgery with crystalloid (Bretschneider) cardioplegic arrest, were allocated in a prospective, randomized, single-blinded protocol to receive either a RIPC protocol (3 cycles of 5 min transient left upper arm ischemia induced by inflating a blood pressure cuff to 200 mmHg with 5 min of reperfusion) or control, respectively, after induction of anesthesia. Cardiac troponin I (cTnI) concentration was measured preoperatively and over 72 h postoperatively, and the area under the curve (AUC) was calculated. Peak postoperative cTnI concentration was significantly reduced from 13.7 +/- 7.7 ng/mL in controls to 8.9 +/- 4.4 ng/mL in RIPC (P = 0.008). Mean cTnI concentration was significantly lower at 6, 12, 24, and 48 h after surgery (ANOVA; P < 0.0001) in the RIPC patients (N = 27) than in controls (N = 26), resulting in a 44.5% reduction of cTnI (AUC at 72 h). RIPC by repetitive inflation of a cuff around the left upper arm before surgery enhances myocardial protection in patients undergoing CABG surgery with antegrade cold crystalloid cardioplegia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495811     DOI: 10.1007/s00395-010-0104-5

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  74 in total

Review 1.  Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery?

Authors:  Jakub Marczak; Rafal Nowicki; Julita Kulbacka; Jolanta Saczko
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-26

Review 2.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 3.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

Review 4.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

Review 5.  Remote conditioning the heart overview: translatability and mechanism.

Authors:  Michael Rahbek Schmidt; Andrew Redington; Hans Erik Bøtker
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

6.  Remote ischaemic preconditioning of the lung: from bench to bedside-are we there yet?

Authors:  Nina C Weber; Coert J Zuurbier; Markus W Hollmann
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

7.  Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.

Authors:  Derek J Hausenloy; Luciano Candilio; Chris Laing; Gudrun Kunst; John Pepper; Shyam Kolvekar; Richard Evans; Steve Robertson; Rosemary Knight; Cono Ariti; Tim Clayton; Derek M Yellon
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

Review 8.  Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).

Authors:  Carina Benstoem; Christian Stoppe; Oliver J Liakopoulos; Julia Ney; Dirk Hasenclever; Patrick Meybohm; Andreas Goetzenich
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

Review 9.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

10.  Remote vs. local ischaemic preconditioning in the rat heart: infarct limitation, suppression of ischaemic arrhythmia and the role of reactive oxygen species.

Authors:  Michael M Galagudza; Dmitry L Sonin; Timur D Vlasov; Dmitry I Kurapeev; Eugene V Shlyakhto
Journal:  Int J Exp Pathol       Date:  2016-03-18       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.